Study Finds Electronic Health Records Not Ready for Genetic Information

Current electronic health records (EHRs) have a long way to go to meet the challenges of genetic/genomic medicine, reports a study in the July issue of Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics.

Although EHR systems have the potential to help integrate genetic information into everyday health care, they'll need new structure, standardization, and functionality to meet this goal, according to the new study led by Dr. Maren Scheuner of RAND Corp., Santa Monica, Calif. The researchers interviewed medical geneticists, genetic counselors, primary care doctors, and EHR vendors and specialists regarding the present and future role of EHRs in storing and using genetic information.

State-of-the-art EHRs lack the features needed even to record genetic information in a systematic way--much less use it in medical decision making, the responses indicated. While current EHR systems provide space for information on the patient's family history, there were limitations on how the information could be entered and used. For example, few systems were able to create or store a pedigree charting the inheritance of genetic conditions within families. EHRs provided little clinical decision support to help doctors assess the risk of genetic diseases or provide treatment alerts based on the family history. Systems also varied in the way they handled the security of genetic test results.

Three-fourths of the health care providers interviewed felt that current EHR systems did not meet their needs for genetic/genomic medicine. At the same time, most perceived little to no demand for such capabilities from health care providers. EHR vendors supported this view--when it came to genetic content, they felt their customers wanted "just the basics."

Most participants thought that genetic/genomic medicine had yet to have much impact on health information technology and EHRs. However, many felt that genetic information would significantly affect patient care within the next decade, including such areas as risk assessment and management, disease prevention, and personalized medical care. They also thought that EHRs had the potential to affect the delivery of genetic/genomic medicine--for example, in managing genetic information, aiding medical decision-making, the use of genetic services, and promoting genetic research.

Electronic health records are expected to play an increasingly important role in medical care in the years ahead. Experts believe that EHRs could play an important role in helping to move genetic information into clinical practice, including educating health care providers about the proper use of genetic data in medical decision making.

"However, basic requirements must be addressed by EHR products before they can effectively facilitate adoption of genetic/genomic information," Scheuner and co-authors concluded. The study helps identify key areas for improvement of EHRs in recording and displaying family history, documenting, and organizing genetic tests and results, providing support for doctors' decision making, and addressing the privacy and security of genetic information.

The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, pharmacy, and the pharmaceutical industry.

Product Showcase

  • EMSL Analytical, Inc. - Air Sampling Supplies & Testing Labs

    EMSL Analytical, Inc. operates laboratories throughout the United States and Canada. EMSL is a nationally recognized and locally focused provider specializing in fast laboratory results for Asbestos, Mold, Silica, Lead & Metals, Bacteria, Legionella, USP , Combustion By-Products, VOC’s, Radon, PCB’s, Formaldehyde, METH/Fentanyl, Identification of Dust & Unknowns. Sampling Pumps, Cassettes, Media & Supplies available. Reach us at 1-800.220.3675 Read More

  • SwabTek® Cannabis Test Kit

    The SwabTek® Cannabis Test Kit is a single-use spot test designed for use in screening for cannabis compounds in any sample type or on any surface. The test is capable of identifying the presumed presence of cannabinoids in very small quantities, with a level of detection as little as 6 μg in mass. Learn more about the SwabTek® Cannabis Test Kit and the rest of SwabTek surface drug testing solutions through the webinar titled "Everything You Want To Know About Surface Testing" Read More

  • Magid® D-ROC® GPD412 21G Ultra-Thin Polyurethane Palm Coated Work Gloves

    Magid’s 21G line is more than just a 21-gauge glove, it’s a revolutionary knitting technology paired with an advanced selection of innovative fibers to create the ultimate in lightweight cut protection. The latest offering in our 21G line provides ANSI A4 cut resistance with unparalleled dexterity and extreme comfort that no other 21-gauge glove on the market can offer! Read More

Featured

Artificial Intelligence

Webinars